3-(Dimethylamino)-4,5-dihydroxyhexanal

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 3-(Dimethylamino)-4,5-dihydroxyhexanal
• 化学式: C₈H₁₇NO₃
• 分子量: 175.23
• InChiKey: WMUYJHSRMOORHK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.1
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  60.8
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Pluraflavins and derivatives thereof, process for their preparation and use thereof
  申请人：——

  公开号：US20020028921A1

  公开（公告）日：2002-03-07

  The invention relates to a compound of formula (l) 1 wherein R 1 is a sugar; R 2 is —CH 2 —O—(R 7 )m, R 7 representing a sugar, or is —COOH; R 3 is an epoxide-comprising group, or is C 1 -C 6 -alkyl or C 2 -C 6 -alkenyl, unsubstituted or substituted by at least one OH; R 5 is H, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl or C 2 -C 6 -alkynyl; R 4 R 6 , R 8 and R 10 independently of one another are H; C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, -X 2 H, or -X 2 R 12 , or R 4 and R 6 together and/or R 8 and R 10 together are=X 2 ; X 2 is O, NH, N-C 1 -C 6 -alkyl, N-C 2 -C 6 -alkenyl, N-C 2 -C 6 -alkynyl or S; R 12 is C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, aryl or acyl; and m and n are 1 or 2; in any of its stereochemical forms and mixtures of these forms in any ratio, and a physiologically acceptable salt or derivative thereof. The compounds are obtainable from a culture of the microorganism Actinomycetales species HAG 003959, DSM 12931, by fermentation. Accordingly, the invention relates to a process for their preparation and to the use of the compounds as pharmaceuticals, for example as antitumor agents.

  本发明涉及一种式（l）化合物 1 其中 R 1 是糖；R 2 是-CH 2 -O-(R 7 )m，R 7 代表一种糖，或者是-COOH； R 3 是由环氧化物组成的基团，或者是 C 1 -C 6 -烷基或 C 2 -C 6 -烯基，未被取代或被至少一个 OH 取代； R 5 是 H、C 1 -C 6 -烷基、C 2 -C 6 -烯基或 C 2 -C 6 -炔基；R 4 R 6 , R 8 和 R 10 各自独立地为 H 1 -C 6 -烷基、C 2 -C 6 -烯基、C 2 -C 6 -炔基、-X 2 H，或-X 2 R 12 或 R 4 和 R 6 和/或 R 8 和 R 10 一起是等价物；X 2 ; X 2 是 O、NH、N-C 1 -C 6 -烷基、N-C 2 -C 6 -烯基、N-C 2 -C 6 -炔基或 S； R 12 是 C 1 -C 6 -烷基、C 2 -C 6 -烯基、C 2 -C 6 -炔基、芳基或酰基；且 m 和 n 为 1 或 2；其任何立体化学形式和这些形式以任何比例的混合物，以及其生理上可接受的盐或衍生物。这些化合物可通过发酵从放线菌属 HAG 003959，DSM 12931 微生物的培养物中获得。因此，本发明涉及制备这些化合物的工艺以及将这些化合物用作药物，例如用作抗肿瘤剂。
• PLURAFLAVINS AND DERIVATIVES THEREOF, PROCESS FOR THEIR PREPARATION AND USE THEREOF
  申请人：Aventis Pharma Deutschland GmbH

  公开号：EP1259523A2

  公开（公告）日：2002-11-27
• US6500936B2
  申请人：——

  公开号：US6500936B2

  公开（公告）日：2002-12-31
• [EN] PLURAFLAVINS AND DERIVATIVES THEREOF, PROCESS FOR THEIR PREPARATION AND USE THEREOF<br/>[FR] PLURAFLAVINES ET LEURS DERIVES, PROCESSUS DE PREPARATION ET UTILISATION CORRESPONDANTE
  申请人：AVENTIS PHARMA GMBH

  公开号：WO2001060832A2

  公开（公告）日：2001-08-23

  The invention relates to a compound of formula (I) wherein R1 is a sugar; R2 is -CH2-O-(R7)m, R7 representing a sugar, or R2 is -COOH; R3 is an epoxide-comprising group, C1-C6-alkyl or C2-C6-alkenyl, unsubstituted or substituted by at least one OH; R5 is H, C1-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl; R4, R6, R8 and R10 independently of one another are H,C1-C6-alkyl, C2-C6-alkenyl, C2-C6-Alkynyl, -X2H, or -X2R12, or R4 and R6 together and/or R8 and R10 together are =X2; X2 is O, NH, N-C1-C6-alkyl, N-C2-C6-alkenyl, N-C2-C6-alkynyl or S; R12 is C1-C6-Alkenyl, C2-C6-alkynyl, C2-C6-alkynyl, aryl or acyl; and m and n are 1 or 2; and its physiologically acceptable salts. The compounds are obtainable from a culture of the microorganism Actinomycetales species HAG 003959, DSM 12931, by fermentation. Accordingly, the invention relates to a process for their preparation and to the use of the compounds as pharmaceuticals, for example as anti-tumor agents.